Guanfacine

Product manufactured by Bryant Ranch Prepack

Application Nr Approved Date Route Status External Links
ANDA205689 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Guanfacine Extended-Release Tablets Are Indicated For The Treatment Of Attention Deficit Hyperactivity Disorder (Adhd) As Monotherapy And As Adjunctive Therapy To Stimulant Medications [See Clinical Studies (14)] . Guanfacine Extended-Release Tablets Are A Central Alpha 2a -Adrenergic Receptor Agonist Indicated For The Treatment Of Attention Deficit Hyperactivity Disorder (Adhd) As Monotherapy And As Adjunctive Therapy To Stimulant Medications (1, 14).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Guanfacine Hydrochloride GUANFACINE HYDROCHLORIDE ZINC3872738

Comments